DANAHER CORP /DE/ — Investor Relations & Filings

Danaher Corporation is a global science and technology company focused on improving human health. It operates across three primary segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment provides technologies and services to accelerate the development and commercialization of therapies, including biologics and cell and gene therapies. The Life Sciences segment offers tools and technologies that support scientific research and laboratory activities in areas such as molecular oncology and fluid filtration. The Diagnostics segment develops instruments, software, and reagents designed to deliver precise and rapid medical diagnoses. A core component of its strategy is the Danaher Business System (DBS), a proprietary management system that drives continuous improvement and operational excellence across its portfolio of businesses.